Follow the people · Insider

EV

Eric Venker

Insider · President & Immunovant CEO · ROIV

Eric Venker files insider transactions with the SEC as a president & immunovant ceo of Roivant Sciences (ROIV). We hold 10 disclosed purchases and sales filed since 29 March 2022, 4 of them in the last 90 days.

  • Files forROIV
  • Disclosed buys and sells10 in all, 4 in the last 90 days
  • Last disclosure1 September 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 25 March 202228 August 2026President & Immunovant CEO · Roivant Sciences (ROIV)297 Form 4 lines · source: SEC Form 4
  • Filed 28 July 20252 July 2026Chief Executive Officer · Immunovant (IMVT)14 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.